Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis (EVEREST)
This study is ongoing, but not recruiting participants.
Study NCT00170716   Information provided by Northstar Neuroscience
First Received: September 9, 2005   Last Updated: December 18, 2007   History of Changes
This Tabular View shows the required WHO registration data elements as marked by

September 9, 2005
December 18, 2007
September 2004
  • Arm Motor Fugl-Meyer (AMFM) score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]
  • Arm Motor Ability Test (AMAT) score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]
  • Arm Motor Fugl-Meyer (AMFM) score at follow-up week 4
  • Arm Motor Ability Test (AMAT) score at follow-up week 4
Complete list of historical versions of study NCT00170716 on ClinicalTrials.gov Archive Site
  • Box and Block Test score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]
  • Stroke Specific Quality of Life (SSQOL) score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]
  • Serious adverse event rate [ Time Frame: Follow up week 4 and 6 months ] [ Designated as safety issue: Yes ]
  • Box and Block Test score at follow-up week 4
  • Stroke Specific Quality of Life (SSQOL) score at follow-up week 4
  • Serious Adverse Event rate at follow-up week 4 and 6 months
 
Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis
Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Rehabilitation Activities to Enhance Motor Recovery in Patients Suffering From Upper Extremity Hemiparesis Following a Stroke

The purpose of this study is to assess the safety and effectiveness of cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis affecting the upper extremity following a stroke.

Stroke is a leading cause of serious, long-term disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. The 2001 overall death rate for stroke was 58%. Of those who survive, 30 to 50 percent do not regain functional independence, 15 to 30 percent are permanently disabled, and 20% require institutional care at three months after onset.

The most common neurological deficit among these stroke survivors, and thus a substantial contributor to post-stroke disability, is a motor weakness on one (hemiparesis) side of the body. Presently, the only treatment available for patients with motor deficits is rehabilitative therapy. However, many patients are not responsive to standard rehabilitative therapy or achieve a less than satisfactory improvement in function.

The primary objective of this study is to determine the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis (a motor weakness in one half of the body) affecting the upper extremity (shoulder, arm, wrist, hand) following a stroke. In addition to evaluating changes from baseline level, safety and efficacy measures will be compared to patients who undergo the same rehabilitation activities but without cortical stimulation. The two study groups will be compared to determine the degree to which motor function of the affected limb can be improved beyond rehabilitation alone by epidural stimulation of a targeted cortical region.

Phase III
Interventional
Treatment, Randomized, Single Blind (Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study
  • Stroke
  • Hemiparesis
  • Device: Cortical Stimulation and rehabilitation
  • Other: Rehabilitation
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
174
March 2008
 

Inclusion Criteria:

  • Subjects must have an ischemic stroke.
  • Moderate to moderately severe upper-extremity hemiparesis.
  • Aged 21 years or older.

Exclusion Criteria:

  • Primary hemorrhagic stroke.
  • Any additional stroke associated with incomplete motor recovery.
  • Any neurologic or physical condition impairing function of the target extremity.
  • History of seizure disorder.
  • History of spinal cord injury, traumatic brain injury, or spontaneous subdural or epidural hematoma that has resulted in a neurologic deficit.
  • Contraindication to magnetic resonance (MR) imaging.
Both
21 Years and older
No
 
United States
 
 
NCT00170716
VP Clinical Affairs, Northstar Neuroscience
 
Northstar Neuroscience
 
 
Northstar Neuroscience
December 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.